Benchmark analyst David Williams maintains Rigetti Computing (NASDAQ:RGTI) with a Buy and lowers the price target from $10 to $8.
Genprex Inc. Receives Orphan Drug Designation For Immunogene Therapy For Treatment Of SCLC
Globe Newswire
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published